These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 32960902)
1. Doxorubicin-induced p53 interferes with mitophagy in cardiac fibroblasts. Mancilla TR; Davis LR; Aune GJ PLoS One; 2020; 15(9):e0238856. PubMed ID: 32960902 [TBL] [Abstract][Full Text] [Related]
2. Cardiomyocyte specific ablation of p53 is not sufficient to block doxorubicin induced cardiac fibrosis and associated cytoskeletal changes. Feridooni T; Hotchkiss A; Remley-Carr S; Saga Y; Pasumarthi KB PLoS One; 2011; 6(7):e22801. PubMed ID: 21829519 [TBL] [Abstract][Full Text] [Related]
3. SESN2 protects against doxorubicin-induced cardiomyopathy via rescuing mitophagy and improving mitochondrial function. Wang P; Wang L; Lu J; Hu Y; Wang Q; Li Z; Cai S; Liang L; Guo K; Xie J; Wang J; Lan R; Shen J; Liu P J Mol Cell Cardiol; 2019 Aug; 133():125-137. PubMed ID: 31199952 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of AMP-activated protein kinase α (AMPKα) by doxorubicin accentuates genotoxic stress and cell death in mouse embryonic fibroblasts and cardiomyocytes: role of p53 and SIRT1. Wang S; Song P; Zou MH J Biol Chem; 2012 Mar; 287(11):8001-12. PubMed ID: 22267730 [TBL] [Abstract][Full Text] [Related]
5. DNA damage is an early event in doxorubicin-induced cardiac myocyte death. L'Ecuyer T; Sanjeev S; Thomas R; Novak R; Das L; Campbell W; Heide RV Am J Physiol Heart Circ Physiol; 2006 Sep; 291(3):H1273-80. PubMed ID: 16565313 [TBL] [Abstract][Full Text] [Related]
6. p53 prevents doxorubicin cardiotoxicity independently of its prototypical tumor suppressor activities. Li J; Wang PY; Long NA; Zhuang J; Springer DA; Zou J; Lin Y; Bleck CKE; Park JH; Kang JG; Hwang PM Proc Natl Acad Sci U S A; 2019 Sep; 116(39):19626-19634. PubMed ID: 31488712 [TBL] [Abstract][Full Text] [Related]
7. Doxorubicin-induced mitophagy and mitochondrial damage is associated with dysregulation of the PINK1/parkin pathway. Yin J; Guo J; Zhang Q; Cui L; Zhang L; Zhang T; Zhao J; Li J; Middleton A; Carmichael PL; Peng S Toxicol In Vitro; 2018 Sep; 51():1-10. PubMed ID: 29729358 [TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor II receptor-α is a novel stress-inducible contributor to cardiac damage underpinning doxorubicin-induced oxidative stress and perturbed mitochondrial autophagy. Pandey S; Kuo WW; Shen CY; Yeh YL; Ho TJ; Chen RJ; Chang RL; Pai PY; Viswanadha VP; Huang CY; Huang CY Am J Physiol Cell Physiol; 2019 Aug; 317(2):C235-C243. PubMed ID: 31116582 [TBL] [Abstract][Full Text] [Related]
9. Cardiomyocytes, cardiac endothelial cells and fibroblasts contribute to anthracycline-induced cardiac injury through RAS-homologous small GTPases RAC1 and CDC42. Kücük P; Abbey L; Schmitt J; Henninger C; Fritz G Pharmacol Res; 2024 May; 203():107165. PubMed ID: 38561112 [TBL] [Abstract][Full Text] [Related]
10. The Abl1 tyrosine kinase is a key player in doxorubicin-induced cardiomyopathy and its p53/p73 cell death mediated signaling differs in atrial and ventricular cardiomyocytes. Borlak J; Ciribilli Y; Bisio A; Selvaraj S; Inga A; Oh JH; Spanel R J Transl Med; 2024 Sep; 22(1):845. PubMed ID: 39285385 [TBL] [Abstract][Full Text] [Related]
11. Protective effects of dimethyl itaconate in mice acute cardiotoxicity induced by doxorubicin. Shan Q; Li X; Zheng M; Lin X; Lu G; Su D; Lu X Biochem Biophys Res Commun; 2019 Sep; 517(3):538-544. PubMed ID: 31376936 [TBL] [Abstract][Full Text] [Related]
13. Chronic doxorubicin cardiotoxicity is mediated by oxidative DNA damage-ATM-p53-apoptosis pathway and attenuated by pitavastatin through the inhibition of Rac1 activity. Yoshida M; Shiojima I; Ikeda H; Komuro I J Mol Cell Cardiol; 2009 Nov; 47(5):698-705. PubMed ID: 19660469 [TBL] [Abstract][Full Text] [Related]
14. JS-K, a GST-activated nitric oxide donor prodrug, enhances chemo-sensitivity in renal carcinoma cells and prevents cardiac myocytes toxicity induced by Doxorubicin. Qiu M; Ke L; Zhang S; Zeng X; Fang Z; Liu J Cancer Chemother Pharmacol; 2017 Aug; 80(2):275-286. PubMed ID: 28608259 [TBL] [Abstract][Full Text] [Related]
15. Monoamine oxidase-A is a novel driver of stress-induced premature senescence through inhibition of parkin-mediated mitophagy. Manzella N; Santin Y; Maggiorani D; Martini H; Douin-Echinard V; Passos JF; Lezoualc'h F; Binda C; Parini A; Mialet-Perez J Aging Cell; 2018 Oct; 17(5):e12811. PubMed ID: 30003648 [TBL] [Abstract][Full Text] [Related]
16. A small molecule inhibitor of PAI-1 protects against doxorubicin-induced cellular senescence. Ghosh AK; Rai R; Park KE; Eren M; Miyata T; Wilsbacher LD; Vaughan DE Oncotarget; 2016 Nov; 7(45):72443-72457. PubMed ID: 27736799 [TBL] [Abstract][Full Text] [Related]
17. AMPK/PGC1α activation by melatonin attenuates acute doxorubicin cardiotoxicity via alleviating mitochondrial oxidative damage and apoptosis. Liu D; Ma Z; Di S; Yang Y; Yang J; Xu L; Reiter RJ; Qiao S; Yuan J Free Radic Biol Med; 2018 Dec; 129():59-72. PubMed ID: 30172748 [TBL] [Abstract][Full Text] [Related]
18. Sphingosylphosphorylcholine ameliorates doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by reducing excessive mitophagy and mitochondrial dysfunction. Zhou J; Lu Y; Li Z; Wang Z; Kong W; Zhao J Toxicol Appl Pharmacol; 2022 Oct; 452():116207. PubMed ID: 35995203 [TBL] [Abstract][Full Text] [Related]
19. Qishen Granule Protects against Doxorubicin-Induced Cardiotoxicity by Coordinating MDM2-p53-Mediated Mitophagy and Mitochondrial Biogenesis. Li W; Zhang Y; Wang X; Cao J; Qian W; Ling G; Tan N; Jiang J; Sun Q; Li C; Wang W; Wang Y Oxid Med Cell Longev; 2022; 2022():4344677. PubMed ID: 36120600 [TBL] [Abstract][Full Text] [Related]
20. Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart. Hoshino A; Mita Y; Okawa Y; Ariyoshi M; Iwai-Kanai E; Ueyama T; Ikeda K; Ogata T; Matoba S Nat Commun; 2013; 4():2308. PubMed ID: 23917356 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]